Participations à des congrès et colloques internationaux (13)
  1. 3. Dias Nunes, J., Ntemou, E., Van Den Steen, G., Devos, M., & Demeestere, I. (2023). Carboplatin/paclitaxel exposure-induced gonadotoxicity in BRCA-mutated ovarian tissue. Poster présenté à la conférence 50th Meeting of BSRM, Mons, 1-2 December 2023.
  2. 4. Dias Nunes, J., Ntemou, E., Van Den Steen, G., Diaz Vidal, P., Devos, M., & Demeestere, I. (2023). In vitro and in vivo toxicity of carboplatin and paclitaxel . regimen on BRCA-mutated ovarian tissue fragments. Poster présenté à la conférence ESHRE annual meeting, 39th, Copenhagen, 25-28 June 2023.
  3. 5. Alexandri, C., Nguyen, T. T. A., & Van Den Steen, G. (2021). Effect of let-7a mimic as a new pharmaco-protective agent against chemotherapy-induced ovarian damage on subsequent follicular development and oocyte quality using mouse ovarian transplantation model. Poster présenté à la conférence ESHRE (37th: 01/07/2021: Virtual).
  4. 6. Goldrat, O., Van Den Steen, G., Gonzalez-Merino, E., Dechene, J., Gervy Decoster, C., Delbaere, A., Devreker, F., De Maertelaer, V., & Demeestere, I. (2017). Evaluation of letrozol-associated controlled ovarian hyperstimulation efficiency for fertility preservation in breast cancer patients: direct and indirect markers. Poster présenté à la conférence BSRM (38th: 01-02/12/2017: Ostend, Belgium).
  5. 7. Goldrat, O., Van Den Steen, G., Gonzalez-Merino, E., Dechene, J., Gervy Decoster, C., Delbaere, A., Devreker, F., De Maertelaer, V., & Demeestere, I. (2017). Follicular Biomarkers in Controlled Ovarian Hyperstimulation Associated with Letrozole for Fertility Preservation in Breast Cancer Patients. Paper session presented at ISFP congress - International society for fertility preservation (novembre 16th-18th 2017: Vienna, Austria).
  6. 8. Horicks, F., Van Den Steen, G., & Demeestere, I. (2016). Investigation of gonadotrophin-releasing hormone analogues action mechanisms during chemotherapy. 36th BSRM Scientific Meeting, 18 and 19th november 2016 Abstract session presented at (2016-11-19)
  7. 9. Horicks, F., Van Den Steen, G., Dechene, J., & Demeestere, I. (2016). The Gonadoprective effects of gonadotrophine-releasing hormone analogues during chemotherapy act through direct effects on ovarian follicles. Poster présenté à la conférence International Congress on Animal Reproduction (18th: 26-30/06/2016: Tours, France).
  8. 10. Horicks, F., Van Den Steen, G., Dechene, J., & Demeestere, I. (2016). FERTILITY PRESERVATION USING GONADOTROPHIN-RELEASING HORMONE ANALOGUES DURING CHEMOTHERAPY: DIRECT OR INDIRECT ACTION? Poster présenté à la conférence ESHRE Campus: Oocyte maturation: from basics to clinics (03-05/05/2016: Brussels, Belgium).
  9. 11. Horicks, F., Van Den Steen, G., Houben, S., Englert, Y., & Demeestere, I. (2015). GnRH analogues effects on follicular growth and their potential ovarian protection against alkylating agent in mice. Abstract session presented at Spring Meeting of the Belgian Society of Physiology and Pharmacology(24-04-2015)
  10. 12. Horicks, F., Bockstaele, L., Houben, S., Van Den Steen, G., Englert, Y., & Demeestere, I. (2014). Evaluation of the Cyclophosphamide gonadotoxicity and the protective effect of GnRH analogues in mice model. Poster présenté à la conférence World Congress in Reproductive Biology (3rd: 2-4/09/2014: Edimbourg).
  11. 13. Horicks, F., Bockstaele, L., Houben, S., Van Den Steen, G., Englert, Y., & Demeestere, I. (2013). Mice model for investigation of the gonadoprotective effects of the GnRH analogues during chemotherapy: is it relevant? Poster présenté à la conférence Ovarian Club III, The Inverse Pyramid: Regulatng Follicle Number and Oocyte Quality (3rd: November 14-16, 2013: Paris, France).
    12. << Précédent 1 2 Suivant >>